全文获取类型
收费全文 | 9034篇 |
免费 | 405篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 57篇 |
儿科学 | 130篇 |
妇产科学 | 112篇 |
基础医学 | 1108篇 |
口腔科学 | 164篇 |
临床医学 | 607篇 |
内科学 | 2307篇 |
皮肤病学 | 136篇 |
神经病学 | 467篇 |
特种医学 | 433篇 |
外科学 | 1944篇 |
综合类 | 58篇 |
预防医学 | 327篇 |
眼科学 | 110篇 |
药学 | 464篇 |
中国医学 | 17篇 |
肿瘤学 | 1036篇 |
出版年
2023年 | 52篇 |
2022年 | 98篇 |
2021年 | 155篇 |
2020年 | 76篇 |
2019年 | 99篇 |
2018年 | 138篇 |
2017年 | 131篇 |
2016年 | 141篇 |
2015年 | 158篇 |
2014年 | 196篇 |
2013年 | 216篇 |
2012年 | 356篇 |
2011年 | 396篇 |
2010年 | 245篇 |
2009年 | 189篇 |
2008年 | 396篇 |
2007年 | 450篇 |
2006年 | 424篇 |
2005年 | 432篇 |
2004年 | 432篇 |
2003年 | 411篇 |
2002年 | 405篇 |
2001年 | 354篇 |
2000年 | 359篇 |
1999年 | 335篇 |
1998年 | 149篇 |
1997年 | 104篇 |
1996年 | 103篇 |
1995年 | 71篇 |
1994年 | 50篇 |
1993年 | 85篇 |
1992年 | 213篇 |
1991年 | 174篇 |
1990年 | 178篇 |
1989年 | 174篇 |
1988年 | 147篇 |
1987年 | 155篇 |
1986年 | 139篇 |
1985年 | 151篇 |
1984年 | 103篇 |
1983年 | 92篇 |
1982年 | 43篇 |
1979年 | 77篇 |
1978年 | 56篇 |
1977年 | 44篇 |
1974年 | 45篇 |
1973年 | 47篇 |
1971年 | 48篇 |
1968年 | 44篇 |
1967年 | 41篇 |
排序方式: 共有9477条查询结果,搜索用时 15 毫秒
101.
The field of tissue engineering and gene therapy has an exciting and promising future. During the past few years we have
begun a comprehensive effort to investigate the use of myoblasts to improve and expand the treatment of stress urinary incontinence
and bladder dysfunction. Moreover, we can expect the application of myoblast-mediated ex vivo gene transfer in the field of
urology. In this paper we discuss the compositions of and methods involving the use of myogenic or muscle-derived cells for
tissue engineering and cell-mediated gene therapy. 相似文献
102.
103.
104.
105.
106.
Yokoyama H Okudaira M Otani T Sato A Miura J Takaike H Yamada H Muto K Uchigata Y Ohashi Y Iwamoto Y 《Kidney international》2000,58(1):302-311
BACKGROUND: Whether the type of diabetes, race, and year and age of diagnosis affect the incidence of diabetic vascular complications is unknown. That both type 1 and type 2 diabetes occur in the young Japanese population prompted us to investigate whether the type of diabetes and the year of diagnosis are related to the incidence of nephropathy. METHODS: Of the 17,256 diabetic patients who visited the outpatient clinic at our diabetes center between 1965 and 1990, 1578 (9.1%) had early-onset diabetes (diagnosed before the age of 30); of these, 620 (39%) had type 1, and 958 (61%) had type 2 diabetes. The incidence of nephropathy was analyzed in the patients according to postpubertal duration and year of diagnosis. RESULTS: The cumulative incidence of nephropathy after 30 years of postpubertal diabetes was significantly higher (P < 0.0001) in type 2 diabetic patients (44.4%, 95% CI, 37.0 to 51.8%) than in type 1 diabetic patients (20.2%, 95% CI, 14.9 to 25.8%). The incidence of nephropathy among type 1 diabetic patients has declined during the past two decades, whereas it has not among type 2 diabetic patients. The rate ratio for type 2 diabetic patients diagnosed between 1980 and 1984 relative to type 1 diabetic patients diagnosed in the same period was 2.74 (95% CI, 1. 17 to 6.41). CONCLUSIONS: The incidence of nephropathy has declined in Japanese patients with type 1 but not in those with type 2 diabetes. In young Japanese patients, because of the higher incidence of nephropathy in type 2 diabetes and the higher prevalence of type 2 than type 1 diabetes, type 2 diabetes is likely the major cause of diabetic nephropathy. 相似文献
107.
108.
109.
110.
Yoshihito Yokoyama M.D. Hidetoshi Maruyama M.D. Shigemi Sato M.D. Yoshiharu Saito M.D. 《Gynecologic oncology》1997,64(3):411-417
The purposes of this study were to analyze the relationship between retroperitoneal lymph node (RLN) metastasis and clinical and pathologic risk factors in endometrial cancers, and to clarify the correlation between RLN metastasis and survival of patients with the disease. This analysis included 63 patients with endometrial cancer who underwent simultaneous pelvic lymph node (PLN) and paraaortic lymph node (PAN) dissection between April 1988 and December 1995. Patients with stage Ia grade 1 and stage IV disease were excluded from this analysis. Both PLN and PAN metastases were found in 10.0% (4/40) of patients with stage I (FIGO, 1988) disease. Of 14 cases with PLN metastases, 8 (57.1%) had PAN metastases simultaneously, whereas 4 (8.2%) of 49 cases without PLN metastases had PAN metastases. There was no significant relationship between the sites or numbers of positive PLN and PAN metastases. Multivariate analysis revealed that poor grade and deep myometrial invasion had an independent relationship with PAN metastases, whereas vascular space invasion and cervical invasion were independently associated with PLN metastases. When divided into the groups of stage I–II and stage III, the prognosis of patients with RLN metastases was significantly poorer than that of patients without RLN metastases in each stage. Furthermore, survival of patients with PAN metastases was significantly worse compared with that of patients with only PLN metastases (44.4 and 80.0%, respectively,P< 0.05). These results reveal that PLN and PAN metastases occur frequently even in early-stage endometrial cancer, and that RLN metastases, especially PAN metastases, have a serious impact on patient survival. In conclusion, systemically simultaneous pelvic and paraaortic lymphadenectomy is essential for all the patients with endometrial cancer except those with stage Ia grade 1 and stage IV to provide prognostic information and select suitable postoperative treatment as well as to perform accurate FIGO staging, provided the condition of the patient permits. 相似文献